Safety assessment of niraparib individualized starting dose in patients with platinum-sensitive recurrent ovarian cancer: A randomized, double-blind, placebo-controlled, phase III NORA trial.
文献类型：期刊论文
| 作者 | Wang, Jing; Wu, Xiaohua; Zhu, Jianqing; Yin, Rutie; Yang, Jiaxin; Huang, Qidan; Wu, Lingying; Liu, Ziling; Gao, Yunong; Wang, Danbo |
| 刊名 | JOURNAL OF CLINICAL ONCOLOGY
 |
| 出版日期 | 2021-05-20 |
| 卷号 | 39 |
| ISSN号 | 0732-183X |
| DOI | 10.1200/JCO.2021.39.15_suppl.5535 |
| 资助项目 | Zai Lab Other Foundation |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| 出版者 | LIPPINCOTT WILLIAMS & WILKINS |
| WOS记录号 | WOS:000708120603138 |
| 资助机构 | Zai Lab Other Foundation |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/126482]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 作者单位 | 1.Zai Lab Shanghai Co Ltd, Shanghai, Peoples R China 2.Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Beijing, Peoples R China 3.First Hosp Jilin Univ, Changchun, Jilin, Peoples R China 4.Peking Univ Canc Hosp & Inst, Beijing, Peoples R China 5.Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Beijing, Peoples R China 6.China Med Univ, Canc Hosp, Liaoning Canc Hosp & Inst, Shenyang, Peoples R China 7.Harbin Med Univ Canc Hosp, Harbin, Peoples R China 8.Kunming Med Univ, Affiliated Hosp 3, Yunnan Canc Hosp, Kunming, Yunnan, Peoples R China 9.Chongqing Univ Canc Hosp, Chongqing, Peoples R China 10.Shandong Univ, Qilu Hosp, Jinan, Peoples R China |
| 推荐引用方式 GB/T 7714 | Wang, Jing,Wu, Xiaohua,Zhu, Jianqing,et al. Safety assessment of niraparib individualized starting dose in patients with platinum-sensitive recurrent ovarian cancer: A randomized, double-blind, placebo-controlled, phase III NORA trial.[J]. JOURNAL OF CLINICAL ONCOLOGY,2021,39. |
| APA | Wang, Jing.,Wu, Xiaohua.,Zhu, Jianqing.,Yin, Rutie.,Yang, Jiaxin.,...&Dong, Juan.(2021).Safety assessment of niraparib individualized starting dose in patients with platinum-sensitive recurrent ovarian cancer: A randomized, double-blind, placebo-controlled, phase III NORA trial..JOURNAL OF CLINICAL ONCOLOGY,39. |
| MLA | Wang, Jing,et al."Safety assessment of niraparib individualized starting dose in patients with platinum-sensitive recurrent ovarian cancer: A randomized, double-blind, placebo-controlled, phase III NORA trial.".JOURNAL OF CLINICAL ONCOLOGY 39(2021). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。